Integrated digital error suppression for improved detection of circulating tumor DNA
Aaron M. Newman, Alexander F. Lovejoy, Daniel M. Klass et al. · Nature Biotechnology · 2016
Cited by 1,099 works. doi:10.1038/nbt.3520
Authors
- Aaron M. Newman
- Alexander F. Lovejoy
- Daniel M. Klass
- David Matthew Kurtz
- Jacob J. Chabon
- Florian Scherer
- Henning Stehr
- Chih Long Liu
- Scott Victor Bratman
- Carmen Say
- Li Zhou
- Justin R. Carter
- Robert B. West
- George W. Sledge
- Joseph B. Shrager
- Billy W. Loo
- Joel W. Neal
- Heather A. Wakelee
- Maximilian Diehn
- Ash A. Alizadeh
References
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
- Zero-Inflated Poisson Regression, with an Application to Defects in Manufacturing
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- Circulating mutant DNA to assess tumor dynamics
- Free DNA in the serum of cancer patients and the effect of therapy.
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer